115 related articles for article (PubMed ID: 38740518)
1. Readily Available Oral Prebiotic Protein Reactive Oxygen Species Nanoscavengers for Synergistic Therapy of Inflammation and Fibrosis in Inflammatory Bowel Disease.
Yu Y; Yang D; Lin B; Zhu L; Li C; Li X
ACS Nano; 2024 May; 18(21):13583-13598. PubMed ID: 38740518
[TBL] [Abstract][Full Text] [Related]
2. ROS Scavenging and inflammation-directed polydopamine nanoparticles regulate gut immunity and flora therapy in inflammatory bowel disease.
Bao M; Wang K; Li J; Li Y; Zhu H; Lu M; Zhang Y; Fan Q; Han L; Wang K; Wang D; Gao Y; Peng B; Ming Z; Liu W
Acta Biomater; 2023 Apr; 161():250-264. PubMed ID: 36863680
[TBL] [Abstract][Full Text] [Related]
3. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
[TBL] [Abstract][Full Text] [Related]
4. Orally administered covalently-assembled antioxidative peptide nanoparticles for inflammatory bowel disease therapy.
Ma X; Gong H; Liu Y; Liu Y; Ogino K; Xing R; Yan X
J Colloid Interface Sci; 2022 Nov; 626():156-166. PubMed ID: 35780549
[TBL] [Abstract][Full Text] [Related]
5. Liver Fibrosis Amelioration by Macrophage-Biomimetic Polydopamine Nanoparticles via Synergistically Alleviating Inflammation and Scavenging ROS.
Ma Z; Tian X; Yu S; Shu W; Zhang C; Zhang L; Wang F
Mol Pharm; 2024 Jun; 21(6):3040-3052. PubMed ID: 38767388
[TBL] [Abstract][Full Text] [Related]
6. A self-assembled, ROS-responsive Janus-prodrug for targeted therapy of inflammatory bowel disease.
Li S; Xie A; Li H; Zou X; Zhang Q
J Control Release; 2019 Dec; 316():66-78. PubMed ID: 31682913
[TBL] [Abstract][Full Text] [Related]
7. Betulinic acid hydroxamate prevents colonic inflammation and fibrosis in murine models of inflammatory bowel disease.
Prados ME; García-Martín A; Unciti-Broceta JD; Palomares B; Collado JA; Minassi A; Calzado MA; Appendino G; Muñoz E
Acta Pharmacol Sin; 2021 Jul; 42(7):1124-1138. PubMed ID: 32811965
[TBL] [Abstract][Full Text] [Related]
8. Bi-functional astaxanthin macromolecular nanocarriers to alleviate dextran sodium sulfate-induced inflammatory bowel disease.
Zhang X; Su W; Chen Y; Xing S; El-Aty AMA; Song Y; Tan M
Int J Biol Macromol; 2024 Jan; 256(Pt 2):128494. PubMed ID: 38035969
[TBL] [Abstract][Full Text] [Related]
9. Aronia melanocarpa (Michx.) Elliott. attenuates dextran sulfate sodium-induced Inflammatory Bowel Disease via regulation of inflammation-related signaling pathways and modulation of the gut microbiota.
Li Y; Nguepi Tsopmejio IS; Diao Z; Xiao H; Wang X; Jin Z; Song H
J Ethnopharmacol; 2022 Jun; 292():115190. PubMed ID: 35306040
[TBL] [Abstract][Full Text] [Related]
10. Irsogladine maleate ameliorates inflammation and fibrosis in mice with chronic colitis induced by dextran sulfate sodium.
Yamaguchi H; Suzuki K; Nagata M; Kawase T; Sukumaran V; Thandavarayan RA; Kawauchi Y; Yokoyama J; Tomita M; Kawachi H; Watanabe K; Yoneyama H; Asakura H; Takagi R
Med Mol Morphol; 2012 Jun; 45(3):140-51. PubMed ID: 23001296
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticles Derived from the Natural Antioxidant Rosmarinic Acid Ameliorate Acute Inflammatory Bowel Disease.
Chung CH; Jung W; Keum H; Kim TW; Jon S
ACS Nano; 2020 Jun; 14(6):6887-6896. PubMed ID: 32449857
[TBL] [Abstract][Full Text] [Related]
12. Colon-targeted oral nanoparticles based on ROS-scavenging hydroxyethyl starch-curcumin conjugates for efficient inflammatory bowel disease therapy.
Xu C; Chen S; Chen C; Ming Y; Du J; Mu J; Luo F; Huang D; Wang N; Lin Z; Weng Z
Int J Pharm; 2022 Jul; 623():121884. PubMed ID: 35661797
[TBL] [Abstract][Full Text] [Related]
13.
Wang J; Su L; Zhang L; Zeng J; Chen Q; Deng R; Wang Z; Kuang W; Jin X; Gui S; Xu Y; Lu X
J Zhejiang Univ Sci B; 2022 Jun; 23(6):481-501. PubMed ID: 35686527
[TBL] [Abstract][Full Text] [Related]
14. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model.
Laroui H; Dalmasso G; Nguyen HT; Yan Y; Sitaraman SV; Merlin D
Gastroenterology; 2010 Mar; 138(3):843-53.e1-2. PubMed ID: 19909746
[TBL] [Abstract][Full Text] [Related]
15. Mo
Guo H; Guo H; Xie Y; Chen Y; Lu C; Yang Z; Zhu Y; Ouyang Y; Zhang Y; Wang X
Redox Biol; 2022 Oct; 56():102441. PubMed ID: 35985164
[TBL] [Abstract][Full Text] [Related]
16. Graphene oxide exacerbates dextran sodium sulfate-induced colitis via ROS/AMPK/p53 signaling to mediate apoptosis.
Liu S; Xu A; Gao Y; Xie Y; Liu Z; Sun M; Mao H; Wang X
J Nanobiotechnology; 2021 Mar; 19(1):85. PubMed ID: 33766052
[TBL] [Abstract][Full Text] [Related]
17. Oral Administration of Therapeutic Enzyme Capsule for the Management of Inflammatory Bowel Disease.
Liang X; Wen K; Chen Y; Fang G; Yang S; Li Q
Int J Nanomedicine; 2022; 17():4843-4860. PubMed ID: 36262191
[TBL] [Abstract][Full Text] [Related]
18. Orally Administrated Inflamed Colon-Targeted Nanotherapeutics for Inflammatory Bowel Disease Treatment by Oxidative Stress Level Modulation in Colitis.
Min DK; Kim YE; Kim MK; Choi SW; Park N; Kim J
ACS Nano; 2023 Dec; 17(23):24404-24416. PubMed ID: 38039189
[TBL] [Abstract][Full Text] [Related]
19. Polyphenolic Nanoparticle-Modified Probiotics for Microenvironment Remodeling and Targeted Therapy of Inflammatory Bowel Disease.
Hu Q; Li J; Wang T; Xu X; Duan Y; Jin Y
ACS Nano; 2024 May; 18(20):12917-12932. PubMed ID: 38720520
[TBL] [Abstract][Full Text] [Related]
20. Orally administration of cerium oxide nanozyme for computed tomography imaging and anti-inflammatory/anti-fibrotic therapy of inflammatory bowel disease.
Cao Y; Cheng K; Yang M; Deng Z; Ma Y; Yan X; Zhang Y; Jia Z; Wang J; Tu K; Liang J; Zhang M
J Nanobiotechnology; 2023 Jan; 21(1):21. PubMed ID: 36658555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
